The effect of cryoprecipitate and fibrinogen concentrate for treating postpartum hemorrhage: a descriptive study
Not Applicable
- Conditions
- postpartum hemorrhage
- Registration Number
- JPRN-UMIN000042842
- Lead Sponsor
- Juntendo University Faculty of Medicine, Department of Anesthesiology and Pain Medicine
- Brief Summary
Critical bleeding was declared and fibrinogen replacement therapy was performed in 25 patients. Blood loss was group C (median 3197 g) < group F (3243 g) < group CF (5704 g). Estimated total fibrinogen replacement by fibrinogen concentrates was group C (median 879 mg) < group F (3000 mg) < group CF (3842 mg). Fibrinogen levels were measured in all patients before fibrinogen replacement therapy, and all but three patients in group F had fibrinogen levels below 200 mg/dL.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 34
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria were women with congenital hypofibrinogenemia, artificial abortion, or miscarriage.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method